Drawing for KALEIDO

USPTO serial 97878365

KALEIDO

Reviewed by CopyMark Law Group

Reg. 8274524Status 700Registered
Filing date
Status date
Registration date
May 26, 2026
Examiner
WUDARSKY, MINDY CHEK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KALEIDO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rachel Huffstetler

Rachel Huffstetler PIERSON FERDINAND LLP227 Sany Springs Pl, Ste D-147Atlanta, GA 30328United States

Goods and services

ClassDescriptionStatusFirst use
035Business services for clinical trials providers, namely, maintaining a registry of databases for purposes of patient health information and health histories, namely, in the field of clinical trials and clinical trial research; business services for clinical trial providers, namely, the collection, reporting, and analysis of patient health information and health histories for business purposesACTIVEMay 31, 2023
042Providing an online computer database for clinical trial providers featuring patient health information and health histories for scientific and medical research purposes, namely, in the field of clinical trials and clinical trial researchACTIVEMay 31, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 26, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 26, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 26, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 26, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 5, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 5, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 14, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 20, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 20, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 5, 2025IUAFUSE AMENDMENT FILED—
Nov 5, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 6, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 19, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 14, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Feb 14, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 14, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 14, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 26, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 26, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Nov 26, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Nov 25, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 25, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 25, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 26, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 26, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 26, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 17, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 16, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 16, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 16, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 16, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2024DOCKASSIGNED TO EXAMINER—
May 2, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 11, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance